Insulinoma in a patient with chronic renal failure due to type 2 diabetes mellitus treated effectively with diazoxide

Intern Med. 2015;54(6):621-5. doi: 10.2169/internalmedicine.54.3621. Epub 2015 Jan 15.

Abstract

A 63-year-old man was diagnosed with diabetes mellitus at 42 years of age. He subsequently exhibited poor blood glucose control for a prolonged period, and his renal failure worsened. He therefore underwent hemodialysis and abdominal magnetic resonance imaging, which revealed a mass in the pancreatic tail. The immunoreactive insulin and C-peptide immunoreactivity levels were significantly elevated, and the results of a fasting test led to a diagnosis of insulinoma. The patient received treatment with oral diazoxide and continuous glucose monitoring (CGM), which resulted in the resolution of the hypoglycemia. This is a rare case of renal failure in which the CGM findings showed improvements in the blood glucose level after diazoxide administration.

Publication types

  • Case Reports

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Biomarkers, Tumor / blood*
  • Blood Glucose / metabolism*
  • C-Peptide / blood
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications*
  • Diazoxide / therapeutic use*
  • Humans
  • Hypoglycemia / blood
  • Hypoglycemia / etiology
  • Hypoglycemia / prevention & control*
  • Insulin / blood
  • Insulinoma / complications*
  • Kidney Failure, Chronic / drug therapy*
  • Kidney Failure, Chronic / etiology*
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / complications*
  • Renal Dialysis
  • Treatment Outcome
  • Vasodilator Agents / therapeutic use

Substances

  • Antihypertensive Agents
  • Biomarkers, Tumor
  • Blood Glucose
  • C-Peptide
  • Insulin
  • Vasodilator Agents
  • Diazoxide